10-Q Filing

MITESCO, INC. CIK: 802257 Q2 2012

Filing Information

Form Type	10-Q
Accession Number	`0001019056-12-000237`
Period End Date	20111231
Filing Date	20120221
Fiscal Year	2012
Fiscal Period	Q2
XBRL Instance	tntyob-20111231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 40 Income Statement 40 Cash Flow Statement 38

Balance Sheet 40 line items

Line Item	Tag	Value	Unit	Period
Preferred stock shares authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Preferred stock shares authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Preferred stock par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$291.00	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$5.34K	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$5.00K	USD	Point-in-time
Preferred stock par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$291.00	USD	Point-in-time
Preferred stock shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
PATENTS-net	`FiniteLivedIntangibleAssetsNet`	$8.88K	USD	Point-in-time
Common stock par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
PATENTS-net	`FiniteLivedIntangibleAssetsNet`	$8.50K	USD	Point-in-time
Common stock shares authorized	`CommonStockSharesAuthorized`	47.00M	shares	Point-in-time
Common stock shares authorized	`CommonStockSharesAuthorized`	47.00M	shares	Point-in-time
Total Assets	`Assets`	$9.17K	USD	Point-in-time
Total Assets	`Assets`	$8.50K	USD	Point-in-time
Common stock shares issued	`CommonStockSharesIssued`	875,763.00	shares	Point-in-time
Common stock shares issued	`CommonStockSharesIssued`	875,763.00	shares	Point-in-time
Notes Payable-related party	`NotesPayableRelatedPartiesClassifiedCurrent`	$75.00K	USD	Point-in-time
Common stock shares outstanding	`CommonStockSharesOutstanding`	875,763.00	shares	Point-in-time
Common stock shares outstanding	`CommonStockSharesOutstanding`	875,763.00	shares	Point-in-time
Notes Payable-related party	`NotesPayableRelatedPartiesClassifiedCurrent`	$80.00K	USD	Point-in-time
Accrued interest payable	`InterestPayableCurrent`	$20.31K	USD	Point-in-time
Accrued interest payable	`InterestPayableCurrent`	$17.13K	USD	Point-in-time
Accounts Payable	`AccountsPayableCurrent`	$17.15K	USD	Point-in-time
Accounts Payable	`AccountsPayableCurrent`	$2.65K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$117.46K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$94.78K	USD	Point-in-time
875,763 shares issued and outstanding*	`CommonStockValue`	$35.03K	USD	Point-in-time
875,763 shares issued and outstanding*	`CommonStockValue`	$35.03K	USD	Point-in-time
Additional Paid-in Capital	`AdditionalPaidInCapitalCommonStock`	$129.25K	USD	Point-in-time
Additional Paid-in Capital	`AdditionalPaidInCapitalCommonStock`	$129.25K	USD	Point-in-time
Accumulated deficit during development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$273.24K	USD	Point-in-time
Accumulated deficit during development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$249.89K	USD	Point-in-time
Total Stockholders' Deficiency	`StockholdersEquity`	$-108.96K	USD	Point-in-time
Total Stockholders' Deficiency	`StockholdersEquity`	$-85.61K	USD	Point-in-time
Total Liabilities and Stockholders' Deficiency	`LiabilitiesAndStockholdersEquity`	$9.17K	USD	Point-in-time
Total Liabilities and Stockholders' Deficiency	`LiabilitiesAndStockholdersEquity`	$8.50K	USD	Point-in-time

Income Statement 40 line items

Line Item	Tag	Value	Unit	Period
Sales and Administrative Expenses	`SellingGeneralAndAdministrativeExpense`	$15.32K	USD	1 Quarter
Sales and Administrative Expenses	`SellingGeneralAndAdministrativeExpense`	$3.17K	USD	1 Quarter
Sales and Administrative Expenses	`SellingGeneralAndAdministrativeExpense`	$247.78K	USD	114 Qtrs
Sales and Administrative Expenses	`SellingGeneralAndAdministrativeExpense`	$19.79K	USD	2 Qtrs
Sales and Administrative Expenses	`SellingGeneralAndAdministrativeExpense`	$7.78K	USD	2 Qtrs
Amortization	`AdjustmentForAmortization`	$189.00	USD	1 Quarter
Amortization	`AdjustmentForAmortization`	$189.00	USD	1 Quarter
Amortization	`AdjustmentForAmortization`	$378.00	USD	2 Qtrs
Amortization	`AdjustmentForAmortization`	$5.14K	USD	114 Qtrs
Amortization	`AdjustmentForAmortization`	$378.00	USD	2 Qtrs
NET LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-15.51K	USD	1 Quarter
NET LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-3.36K	USD	1 Quarter
NET LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-8.15K	USD	2 Qtrs
NET LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-252.93K	USD	114 Qtrs
NET LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-20.17K	USD	2 Qtrs
Other Income	`OtherNonoperatingIncome`	$-10.00K	USD	1 Quarter
Interest	`InterestExpense`	$3.18K	USD	2 Qtrs
Interest	`InterestExpense`	$2.81K	USD	2 Qtrs
Interest	`InterestExpense`	$1.61K	USD	1 Quarter
Interest	`InterestExpense`	$20.31K	USD	114 Qtrs
Interest	`InterestExpense`	$1.49K	USD	1 Quarter
SUBTOTAL	`OtherOperatingIncomeExpenseNet`	$-11.61K	USD	1 Quarter
SUBTOTAL	`OtherOperatingIncomeExpenseNet`	$-1.49K	USD	1 Quarter
SUBTOTAL	`OtherOperatingIncomeExpenseNet`	$-3.18K	USD	2 Qtrs
SUBTOTAL	`OtherOperatingIncomeExpenseNet`	$-2.81K	USD	2 Qtrs
SUBTOTAL	`OtherOperatingIncomeExpenseNet`	$-20.31K	USD	114 Qtrs
NET LOSS	`NetIncomeLoss`	$-27.12K	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-273.24K	USD	114 Qtrs
NET LOSS	`NetIncomeLoss`	$-273.24K	USD	110 Qtrs
NET LOSS	`NetIncomeLoss`	$-4.84K	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-10.96K	USD	2 Qtrs
NET LOSS	`NetIncomeLoss`	$-23.35K	USD	2 Qtrs
Basic and diluted (in Dollars per share)	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	$-0.03	USD	2 Qtrs
Basic and diluted (in Dollars per share)	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	$-0.01	USD	1 Quarter
Basic and diluted (in Dollars per share)	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	$-0.03	USD	1 Quarter
Basic and diluted (in Dollars per share)	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	$-0.01	USD	2 Qtrs
Basic and diluted	`WeightedAverageNumberOfSharesOutstanding-BasicAndDiluted`	$875.76K	USD	2 Qtrs
Basic and diluted	`WeightedAverageNumberOfSharesOutstanding-BasicAndDiluted`	$875.76K	USD	1 Quarter
Basic and diluted	`WeightedAverageNumberOfSharesOutstanding-BasicAndDiluted`	$875.76K	USD	2 Qtrs
Basic and diluted	`WeightedAverageNumberOfSharesOutstanding-BasicAndDiluted`	$875.76K	USD	1 Quarter

Cash Flow Statement 38 line items

Line Item	Tag	Value	Unit	Period
Net Loss	`NetIncomeLoss`	$-27.12K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-273.24K	USD	114 Qtrs
Net Loss	`NetIncomeLoss`	$-273.24K	USD	110 Qtrs
Net Loss	`NetIncomeLoss`	$-4.84K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-10.96K	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-23.35K	USD	2 Qtrs
Amortization	`AmortizationOfIntangibleAssets`	$5.14K	USD	110 Qtrs
Amortization	`AmortizationOfIntangibleAssets`	$378.00	USD	2 Qtrs
Amortization	`AmortizationOfIntangibleAssets`	$378.00	USD	2 Qtrs
Capital stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$24.73K	USD	110 Qtrs
Changes in accounts payable	`IncreaseDecreaseInAccountsPayable`	$17.15K	USD	110 Qtrs
Changes in accounts payable	`IncreaseDecreaseInAccountsPayable`	$-2.56K	USD	2 Qtrs
Changes in accounts payable	`IncreaseDecreaseInAccountsPayable`	$14.50K	USD	2 Qtrs
Changes in accrued interest payable-related party	`IncreaseDecreaseInInterestPayableNet`	$2.81K	USD	2 Qtrs
Changes in accrued interest payable-related party	`IncreaseDecreaseInInterestPayableNet`	$3.18K	USD	2 Qtrs
Changes in accrued interest payable-related party	`IncreaseDecreaseInInterestPayableNet`	$20.31K	USD	110 Qtrs
Net Cash (used in) Operations	`NetCashProvidedByUsedInOperatingActivities`	$-5.29K	USD	2 Qtrs
Net Cash (used in) Operations	`NetCashProvidedByUsedInOperatingActivities`	$-10.34K	USD	2 Qtrs
Net Cash (used in) Operations	`NetCashProvidedByUsedInOperatingActivities`	$-205.91K	USD	110 Qtrs
Purchase of patent	`PaymentsToAcquireIntangibleAssets`	$13.65K	USD	110 Qtrs
Net cash (used in) Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	$-13.65K	USD	110 Qtrs
Proceeds from note payable-related party	`ProceedsFromRelatedPartyDebt`	$10.00K	USD	2 Qtrs
Proceeds from note payable-related party	`ProceedsFromRelatedPartyDebt`	$5.00K	USD	2 Qtrs
Proceeds from note payable-related party	`ProceedsFromRelatedPartyDebt`	$80.00K	USD	110 Qtrs
Contributions to capital	`ProceedsFromContributedCapital`	$3.70K	USD	110 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$135.85K	USD	110 Qtrs
Net cash provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$219.55K	USD	110 Qtrs
Net cash provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$5.00K	USD	2 Qtrs
Net cash provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$10.00K	USD	2 Qtrs
Net Change in Cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-340.00	USD	2 Qtrs
Net Change in Cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-291.00	USD	2 Qtrs
Cash at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$291.00	USD	Point-in-time
Cash at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$5.34K	USD	Point-in-time
Cash at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$5.00K	USD	Point-in-time
Cash at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$291.00	USD	Point-in-time
Cash at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$5.34K	USD	Point-in-time
Cash at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$5.00K	USD	Point-in-time
Stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$24.73K	USD	110 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.